It's a troubling trend, and a researcher here in Michigan is leading the push to find out why it's occurring as cases of Alzheimer's Disease are skyrocketing among Black Americans.

The screening tool called “The Sage Test” was inspired by a doctor’s desire to help his patients by aiming to identify memory problems months in advance than the current test does.

The first dose of a new FDA-approved drug to treat Alzheimer’s disease was administered by the Michigan Institute of Neurological Disorders (MIND) on Wednesday.